Floriano Paes Silva-Jr (Floriano P Silva-Jr, Floriano Silva-Jr, Floriano Junior, Floriano Paes Silva, Floriano Paes Silva-Junior)

ResearcherID Scopus Author ID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Venues

Memorias do Instituto Oswaldo Cruz

BMC chemistry

Pharmaceuticals (Basel, Switzerland)

Journal of chemical information and modeling

FIOCRUZ

Universidade Federal do Rio de Janeiro (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

FIOCRUZ

Brazil

Researcher :: Oswaldo Cruz Institute

Education History

Universidade Federal do Rio de Janeiro

Brazil

PHD

Publications

Luiz Carlos Saramago, Marcos V Santana, Bárbara Figueira Gomes, Rafael Ferreira Dantas, Mario R Senger, Pedro Henrique Oliveira Borges, Vivian Neuza Dos Santos Ferreira, Alice Dos Santos Rosa, Amanda Resende Tucci, Milene Dias Miranda, Petra Lukacik, Claire Strain-Damerell, C David Owen, Martin Austin Walsh, Sabrina Baptista Ferreira, Floriano Paes Silva-Jr
AI-Driven Discovery of SARS-CoV-2 Main Protease Fragment-like Inhibitors with Antiviral Activity In Vitro . Journal of chemical information and modeling (2023)
Bárbara Figueira Gomes, Mario Roberto Senger, José Teófilo Moreira-Filho, Fabio Jorge de Vasconcellos Junior, Rafael Ferreira Dantas, Raymond Owens, Carolina Horta Andrade, Bruno Junior Neves, Floriano Paes Silva-Jr
Discovery of new Schistosoma mansoni aspartyl protease inhibitors by structure-based virtual screening. Memorias do Instituto Oswaldo Cruz 118 (2023)
Rafael Ferreira Dantas, Eduardo Caio Torres-Santos, Floriano Paes Silva-Jr
Past and future of trypanosomatids high-throughput phenotypic screening. Memorias do Instituto Oswaldo Cruz 117 (2022)
Carine Santos, Luiz Claudio Ferreira Pimentel, Henayle Canzian, Andressa Oliveira, Floriano Paes Silva-Jr, Rafael Dantas, Lucas Hoelz, Debora Marinho, Anna Claudia Cunha, Monica Bastos, Nubia Boechat
Hybrids of Imatinib with Quinoline: Synthesis, Antimyeloproliferative Activity Evaluation, and Molecular Docking. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Andressa Oliveira, Stefany Moura, Luiz Claudio Ferreira Pimentel, João Neto, Rafael Dantas, Floriano Paes Silva-Jr, Monica Bastos, Nubia Boechat
New Imatinib Derivatives with Antiproliferative Activity against A549 and K562 Cancer Cells. Molecules (Basel, Switzerland) 27 (3) (2022)
Marcos V S Santana, Floriano Paes Silva-Jr
De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning. BMC chemistry 15 (1) (2021)
Mario Roberto Senger, Tereza Cristina Santos Evangelista, Rafael Ferreira Dantas, Marcos Vinicius da Silva Santana, Luiz Carlos Saramago Gonçalves, Lauro Ribeiro de Souza Neto, Sabrina Baptista Ferreira, Floriano Paes Silva-Jr
COVID-19: molecular targets, drug repurposing and new avenues for drug discovery. Memorias do Instituto Oswaldo Cruz 115 (2020)
Pedro Henrique Monteiro Torres, Ana C R Sodero, Paula Jofily, Floriano Paes Silva-Jr
Key Topics in Molecular Docking for Drug Design. International journal of molecular sciences 20 (18) (2019)
Carolina Escardó Pereyra, Rafael Ferreira Dantas, Sabrina Baptista Ferreira, Luciano Pinho Gomes, Floriano Paes Silva-Jr
The diverse mechanisms and anticancer potential of naphthoquinones. Cancer cell international 19 (2019)

Floriano Paes Silva-Jr.css-eqlu8i{font-size:small;padding-left:4px;} (Floriano P Silva-Jr, Floriano Silva-Jr, Floriano Junior, Floriano Paes Silva, Floriano Paes Silva-Junior)

Publication Activity (10 Years)

Top Topics

Top Venues

Floriano Paes Silva-Jr (Floriano P Silva-Jr, Floriano Silva-Jr, Floriano Junior, Floriano Paes Silva, Floriano Paes Silva-Junior)